The BMT Program at Ohio State University runs a number of novel clinical trials aimed at improving outcomes in patients with several different types of blood cancers. We are particularly focused on patients with acute leukemia, multiple myeloma and non-Hodgkins lymphoma.
The BMT Program treats patients at all disease stages; however, we are very interested in enhancing outcomes in patients with poor risk leukemias treated in first remission.
The types of diseases we treat include:
Acute Lymphocytic Leukemia ALL
Acute Myeloid Leukemia (Adult)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia